Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	olfactory receptor activity	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	2.24e-14	431	231	29	GO:0004984
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR5M10 OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 TAAR3P ADGRV1 GPR179 FZD6 OR51E1 OR13D1 OR2AT4 OR2A4 AGTR1 OR5C1 TACR2 GNRHR OR8J2 OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 LPAR2 OR4K5 LGR6 OR51G1	2.27e-14	884	231	41	GO:0004930
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	OR5M10 OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 TAAR3P ADGRV1 GPR179 CHRNG FZD6 OR51E1 OR13D1 OR2AT4 OR2A4 AGTR1 OR5C1 TACR2 GNRHR NOTCH1 OR8J2 OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P GRID2 OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 SCARB2 OR5H8 LPAR2 OR4K5 LGR6 OR51G1	1.04e-10	1353	231	45	GO:0004888
GeneOntologyMolecularFunction	odorant binding	OR5M10 OR2A7 OR5M1 OR10V1 OR2A4 OR5C1 OR8J2 OR9Q2 OR5A1 OR5AK3P OR8J1 OR6K6 OR2C1 OR5H8	2.53e-10	127	231	14	GO:0005549
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 DYNC1H1 DYNC2H1 DNAH7	4.70e-05	18	231	4	GO:0008569
GeneOntologyMolecularFunction	chondroitin-glucuronate 5-epimerase activity	DSE DSEL	1.33e-04	2	231	2	GO:0047757
GeneOntologyMolecularFunction	oxidoreductase activity	ABCC4 CYP8B1 BCKDHA NDUFA9 FADS2B PTGIS F8 DUS1L GLDC SMOX PLOD2 NOS3 MPO SCO2 PTGES XDH SDR42E1 FADS6 CRYL1 TYW5 UEVLD	2.36e-04	766	231	21	GO:0016491
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH14 DYNC1H1 DYNC2H1 DNAH7	2.87e-04	28	231	4	GO:0051959
GeneOntologyMolecularFunction	protein O-acetylglucosaminyltransferase activity	OGT POMGNT2	3.97e-04	3	231	2	GO:0097363
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	1.06e-14	432	231	29	GO:0050911
GeneOntologyBiologicalProcess	sensory perception	OR5M10 OR2A7 OR9A4 OR5M1 ASIC1 OR13C4 OR10V1 OR2W1 TAAR3P ADGRV1 GPR179 BSND OR51E1 OR13D1 OR2AT4 OTOF OR2A4 HPS1 PCDH15 OR5C1 PPIP5K2 NIPBL OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 PTGES OR5A1 OR5AK3P OR2S2 OR8J1 PPEF2 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 CRYBA1 EYS HMCN1 SCARB2 OR5H8 OR4K5 OR51G1	1.16e-14	1072	231	45	GO:0007600
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 ADGRV1 OR51E1 OR13D1 OR2AT4 OR2A4 PCDH15 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 PPEF2 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 EYS OR5H8 OR4K5 OR51G1	1.72e-14	582	231	33	GO:0050906
GeneOntologyBiologicalProcess	sensory perception of smell	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	6.97e-14	465	231	29	GO:0007608
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	OR5M10 OR2A7 OR9A4 OR5M1 ASIC1 OR13C4 OR10V1 OR2W1 TAAR3P OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	1.17e-13	547	231	31	GO:0007606
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	2.02e-13	485	231	29	GO:0050907
GeneOntologyBiologicalProcess	detection of stimulus	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 CDS2 OR10V1 OR2W1 ADGRV1 OR51E1 OR13D1 OR2AT4 OR2A4 PCDH15 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 PPEF2 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 EYS OR5H8 OR4K5 OR51G1	1.33e-12	722	231	34	GO:0051606
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	1.39e-12	524	231	29	GO:0009593
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR5M10 PDE3A OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 TAAR3P ADGRV1 GPR179 FZD6 OR51E1 OR13D1 OR2AT4 PRMT5 OR2A4 TMEM145 AGTR1 OR5C1 TACR2 C5 GNRHR OR8J2 OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 LPAR2 OR4K5 LGR6 OR51G1	9.91e-11	1395	231	45	GO:0007186
GeneOntologyBiologicalProcess	cilium movement	CATSPERD DNAH14 UBE2B CFAP221 TACR2 DYNC1H1 DYNC2H1 TPGS1 APOB DNAH7 SPAG17 HYDIN	4.08e-05	261	231	12	GO:0003341
GeneOntologyBiologicalProcess	gonadotropin secretion	INHA INHBA TACR2 GNRHR	9.57e-05	22	231	4	GO:0032274
GeneOntologyCellularComponent	inhibin A complex	INHA INHBA	1.21e-04	2	230	2	GO:0043512
GeneOntologyCellularComponent	inhibin complex	INHA INHBA	1.21e-04	2	230	2	GO:0043511
GeneOntologyCellularComponent	manchette	CFAP221 DYNC1H1 PACRG SPAG17	2.38e-04	28	230	4	GO:0002177
MousePheno	decreased prostaglandin level	ABCC4 PTGIS NOS3 PTGES	1.23e-05	13	165	4	MP:0009815
Domain	7tm_1	OR5M10 OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 TAAR3P OR51E1 OR13D1 OR2AT4 OR2A4 AGTR1 OR5C1 TACR2 GNRHR OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR2C1 LPAR2 OR4K5 LGR6 OR51G1	6.01e-12	677	223	33	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR5M10 OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 TAAR3P OR51E1 OR13D1 OR2AT4 OR2A4 AGTR1 OR5C1 TACR2 GNRHR OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR2C1 LPAR2 OR4K5 LGR6 OR51G1	8.24e-12	685	223	33	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR5M10 OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 TAAR3P OR51E1 OR13D1 OR2AT4 OR2A4 AGTR1 OR5C1 TACR2 GNRHR OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR2C1 LPAR2 OR4K5 LGR6 OR51G1	1.04e-11	691	223	33	PS50262
Domain	GPCR_Rhodpsn	OR5M10 OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 TAAR3P OR51E1 OR13D1 OR2AT4 OR2A4 AGTR1 OR5C1 TACR2 GNRHR OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR2C1 LPAR2 OR4K5 LGR6 OR51G1	1.08e-11	692	223	33	IPR000276
Domain	Olfact_rcpt	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 OR6K6 OR1D2 OR2C1 OR4K5 OR51G1	6.29e-11	393	223	24	IPR000725
Domain	GPCR_Rhodpsn_7TM	OR5M10 OR2A7 OR9A4 OR5M1 CYSLTR1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 AGTR1 OR5C1 TACR2 GNRHR OR10P1 GPR35 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 SUCNR1 OR6K6 OR1D2 OR2C1 LPAR2 OR4K5 OR51G1	1.04e-10	670	223	31	IPR017452
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DYNC1H1 DYNC2H1 DNAH7	1.80e-05	14	223	4	IPR024317
Domain	Dynein_HC_stalk	DNAH14 DYNC1H1 DYNC2H1 DNAH7	1.80e-05	14	223	4	IPR024743
Domain	MT	DNAH14 DYNC1H1 DYNC2H1 DNAH7	1.80e-05	14	223	4	PF12777
Domain	AAA_8	DNAH14 DYNC1H1 DYNC2H1 DNAH7	1.80e-05	14	223	4	PF12780
Domain	DHC_fam	DNAH14 DYNC1H1 DYNC2H1 DNAH7	2.44e-05	15	223	4	IPR026983
Domain	Dynein_heavy	DNAH14 DYNC1H1 DYNC2H1 DNAH7	2.44e-05	15	223	4	PF03028
Domain	Dynein_heavy_dom	DNAH14 DYNC1H1 DYNC2H1 DNAH7	2.44e-05	15	223	4	IPR004273
Domain	-	CFAP221 TMEM131 HYDIN	9.00e-05	8	223	3	2.60.40.360
Domain	PapD-like	CFAP221 TMEM131 HYDIN	1.34e-04	9	223	3	IPR008962
Domain	AAA	ABCC4 ABCB4 LONP1 DYNC1H1 DYNC2H1 ABCB6 DNAH7 ORC4	3.41e-04	144	223	8	SM00382
Domain	AAA+_ATPase	ABCC4 ABCB4 LONP1 DYNC1H1 DYNC2H1 ABCB6 DNAH7 ORC4	3.41e-04	144	223	8	IPR003593
Domain	BRINP	BRINP3 BRINP2	4.22e-04	3	223	2	IPR033237
Domain	Otopetrin	OTOP2 OTOP3	4.22e-04	3	223	2	PF03189
Domain	Otopetrin	OTOP2 OTOP3	4.22e-04	3	223	2	IPR004878
Domain	Dynein_heavy_dom-2	DYNC1H1 DYNC2H1 DNAH7	5.55e-04	14	223	3	IPR013602
Domain	DHC_N2	DYNC1H1 DYNC2H1 DNAH7	5.55e-04	14	223	3	PF08393
Domain	DNA_pol_B	POLE REV3L	8.38e-04	4	223	2	PF00136
Domain	Argonaute_N	AGO2 AGO1	8.38e-04	4	223	2	IPR032474
Domain	Argonaute_Mid_dom	AGO2 AGO1	8.38e-04	4	223	2	IPR032473
Domain	ArgoL2	AGO2 AGO1	8.38e-04	4	223	2	IPR032472
Domain	DNA-dir_DNA_pol_B	POLE REV3L	8.38e-04	4	223	2	IPR006172
Domain	DNA-dir_DNA_pol_B_exonuc	POLE REV3L	8.38e-04	4	223	2	IPR006133
Domain	DNA-dir_DNA_pol_B_multi_dom	POLE REV3L	8.38e-04	4	223	2	IPR006134
Domain	DNA_pol_B_exo1	POLE REV3L	8.38e-04	4	223	2	PF03104
Domain	ArgoN	AGO2 AGO1	8.38e-04	4	223	2	PF16486
Domain	ArgoMid	AGO2 AGO1	8.38e-04	4	223	2	PF16487
Domain	ArgoL2	AGO2 AGO1	8.38e-04	4	223	2	PF16488
Domain	POLBc	POLE REV3L	8.38e-04	4	223	2	SM00486
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR4K5 OR51G1	7.21e-12	417	186	27	M4072
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR4K5 OR51G1	5.45e-11	389	186	25	M14091
Pathway	REACTOME_SENSORY_PERCEPTION	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OTOF OR2A4 PCDH15 OR5C1 OR8J2 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR2S2 APOB OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR4K5 OR51G1	1.10e-09	636	186	30	M41834
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR5M10 OR2A7 OR9A4 OR5M1 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	7.11e-20	343	231	26	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR5M10 OR2A7 OR9A4 OR5M1 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	8.85e-20	346	231	26	14611657
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR5M10 OR2A7 OR9A4 OR5M1 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR8J1 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	7.86e-19	340	231	25	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR5M10 OR2A7 OR9A4 OR5M1 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR10P1 OR11H4 OR1S2 OR9Q2 OR5A1 OR5AK3P OR8J1 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	7.86e-19	340	231	25	11802173
Pubmed	The human olfactory receptor gene family.	OR5M10 OR2A7 OR9A4 OR5M1 OR13C4 OR10V1 OR2W1 OR51E1 OR13D1 OR2AT4 OR2A4 OR5C1 OR10P1 OR11H4 OR1S2 OR5A1 OR2S2 OR8J1 OR6K6 OR1D2 OR51F1 OR2C1 OR10D3 OR5H8 OR4K5 OR51G1	4.58e-15	541	231	26	14983052
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	GBF1 MYO1E RAP1GAP2 PARVB CIC DUS1L MAP3K5 SARS2 CCDC3 CAMSAP1 DOCK6 SMURF2 DYNC1H1 NOTCH1 PITPNM2 POLE UBR4 AMBRA1 TWNK DDX56 PPP6R1 REV3L ZNF865 THADA POMGNT2 LRP4 TNK2	6.74e-09	1105	231	27	35748872
Pubmed	DEFOG: a practical scheme for deciphering families of genes.	OR2A7 OR5M1 OR13C4 OR10V1 OR2W1 OR10P1 OR1S2 OR5A1 OR2S2 OR8J1 OR1D2	2.81e-07	219	231	11	12213199
Pubmed	UBE2A and UBE2B are recruited by an atypical E3 ligase module in UBR4.	UBE2A UBE2B UBR4	2.89e-07	3	231	3	38182926
Pubmed	KCMF1 (potassium channel modulatory factor 1) Links RAD6 to UBR4 (ubiquitin N-recognin domain-containing E3 ligase 4) and lysosome-mediated degradation.	UBE2A UBE2B SARS2 OGT UBR4	2.52e-06	33	231	5	25582440
Pubmed	Mutations in a new scaffold protein Sans cause deafness in Jackson shaker mice.	OTOP2 OTOP3 FADS6	2.86e-06	5	231	3	12588793
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	ACLY ADGRV1 EML5 BPI GLG1 C5 NIPBL DYNC1H1 MPO COL6A3 NAGK VWF COL15A1 DYNC2H1 ABCB6 SUCNR1 CRYL1 EYS SCARB2 CDK5RAP2 UEVLD	4.95e-06	1016	231	21	19056867
Pubmed	Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders.	OTOP2 OTOP3 HPS1 GRID2 OCA2 LRP4	8.72e-06	72	231	6	25917818
Pubmed	Localization of the inhibin beta B gene on mouse chromosome 1.	INHA INHBA CHRNG	1.58e-05	8	231	3	8358176
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ABCC4 ACLY FZD6 GLG1 PRMT5 UGT8 UTP20 TTC13 PLOD2 NOTCH1 DSE COL15A1 PTGES PPP6R1 THADA POMGNT2 SCARB2 LRP4 TMEM131 SELENOI DSEL DGAT1	1.91e-05	1201	231	22	35696571
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	CDS2 NDUFA9 HSPA12B CIC C5 NIPBL DYNC2H1 POLE UBR4 REV3L DNAH7 ESF1 CRYL1 MRPS2 CDK5RAP2	2.74e-05	638	231	15	31182584
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	AGO2 CDS2 CIC ASB6 PIP5K1A CAMSAP1 DDX56 PPP6R1 ORC4	3.81e-05	242	231	9	34011540
Pubmed	Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII.	F8 VWF	4.39e-05	2	231	2	15731176
Pubmed	Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.	MAP3K5 CARD6	4.39e-05	2	231	2	29958938
Pubmed	Reduced Expression of Argonaute 1, Argonaute 2, and TRBP Changes Levels and Intracellular Distribution of RNAi Factors.	AGO2 AGO1	4.39e-05	2	231	2	26242502
Pubmed	Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.	F8 VWF	4.39e-05	2	231	2	33221577
Pubmed	Mechano-covalent protection of coagulation factor VIII by von Willebrand factor.	F8 VWF	4.39e-05	2	231	2	36240294
Pubmed	Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.	F8 VWF	4.39e-05	2	231	2	23690449
Pubmed	CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection.	ITGAM C5	4.39e-05	2	231	2	16611225
Pubmed	The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice.	UBE2A UBE2B	4.39e-05	2	231	2	15169909
Pubmed	Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.	F8 VWF	4.39e-05	2	231	2	22219226
Pubmed	Application of machine learning algorithms to predict coronary artery calcification with a sibship-based design.	NOS3 GPR35	4.39e-05	2	231	2	18271057
Pubmed	The role of VWF in the immunogenicity of FVIII.	F8 VWF	4.39e-05	2	231	2	18549909
Pubmed	The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.	F8 VWF	4.39e-05	2	231	2	9218428
Pubmed	The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.	F8 VWF	4.39e-05	2	231	2	7756647
Pubmed	Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.	F8 VWF	4.39e-05	2	231	2	18535282
Pubmed	Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus.	F8 VWF	4.39e-05	2	231	2	20624989
Pubmed	The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.	AGO2 ITCH	4.39e-05	2	231	2	32392088
Pubmed	The influence of von Willebrand factor on factor VIII activity measurements.	F8 VWF	4.39e-05	2	231	2	18983499
Pubmed	Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium.	F8 VWF	4.39e-05	2	231	2	14517489
Pubmed	Notch1 modulates oxidative stress induced cell death through suppression of apoptosis signal-regulating kinase 1.	MAP3K5 NOTCH1	4.39e-05	2	231	2	23569274
Pubmed	Renin-angiotensin system and nitric oxide synthase gene polymorphisms in relation to stroke.	AGTR1 NOS3	4.39e-05	2	231	2	17586411
Pubmed	Surface-exposed hemophilic mutations across the factor VIII C2 domain have variable effects on stability and binding activities.	F8 VWF	4.39e-05	2	231	2	15471879
Pubmed	Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain.	INHA INHBA	4.39e-05	2	231	2	3267209
Pubmed	Lysophosphatidic acid induces the migration and invasion of SGC-7901 gastric cancer cells through the LPA2 and Notch signaling pathways.	NOTCH1 LPAR2	4.39e-05	2	231	2	31115486
Pubmed	Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.	INHA INHBA	4.39e-05	2	231	2	24107149
Pubmed	von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels.	F8 VWF	4.39e-05	2	231	2	20492463
Pubmed	Genetic analysis of the cytoplasmic dynein subunit families.	DYNC1H1 DYNC2H1	4.39e-05	2	231	2	16440056
Pubmed	Involvement of AGO1 and AGO2 in mammalian transcriptional silencing.	AGO2 AGO1	4.39e-05	2	231	2	16936728
Pubmed	Solution structure of the major factor VIII binding region on von Willebrand factor.	F8 VWF	4.39e-05	2	231	2	24700780
Pubmed	The NMR structure of the class I human ubiquitin-conjugating enzyme 2b.	UBE2A UBE2B	4.39e-05	2	231	2	11885984
Pubmed	Argonaute Family Protein Expression in Normal Tissue and Cancer Entities.	AGO2 AGO1	4.39e-05	2	231	2	27518285
Pubmed	Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies.	F8 VWF	4.39e-05	2	231	2	21940821
Pubmed	VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.	F8 VWF	4.39e-05	2	231	2	23349392
Pubmed	Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population.	AGO2 AGO1	4.39e-05	2	231	2	36142498
Pubmed	von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.	F8 VWF	4.39e-05	2	231	2	37756521
Pubmed	Synergistic effect of angiotensin II type 1 receptor and endothelial nitric oxide synthase gene polymorphisms on arterial stiffness.	AGTR1 NOS3	4.39e-05	2	231	2	17728799
Pubmed	Vasoconstrictively acting AT1R A1166C and NOS3 4/5 polymorphisms in recurrent spontaneous abortions (RSA).	AGTR1 NOS3	4.39e-05	2	231	2	15212666
Pubmed	Polymorphisms and expression of genes encoding Argonautes 1 and 2 in autoimmune thyroid diseases.	AGO2 AGO1	4.39e-05	2	231	2	29256262
Pubmed	Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization.	UBE2A UBE2B	4.39e-05	2	231	2	31683936
Pubmed	Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies.	F8 VWF	4.39e-05	2	231	2	17958741
Pubmed	Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis.	F8 VWF	4.39e-05	2	231	2	32032127
Pubmed	Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex.	INHA INHBA	4.39e-05	2	231	2	16873442
Pubmed	Anti-heavy-chain monoclonal antibodies directed to the acidic regions of the factor VIII molecule inhibit the binding of factor VIII to phospholipids and von Willebrand factor.	F8 VWF	4.39e-05	2	231	2	12958606
Pubmed	Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner.	F8 VWF	4.39e-05	2	231	2	37720212
Pubmed	Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.	F8 VWF	4.39e-05	2	231	2	23168412
Pubmed	Involvement of prostacyclin synthase in high-fat-diet-induced obesity.	PTGIS PTGES	4.39e-05	2	231	2	33383181
Pubmed	Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions.	F8 VWF	4.39e-05	2	231	2	15459008
Pubmed	A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.	F8 VWF	4.39e-05	2	231	2	23335368
Pubmed	THE EFFECT OF NOS3 AND AGTR1 GENOTYPES ON THE COURSE OF THE ARTERIAL HYPERTENSION FOR THE OVERWEIGHT OR OBESE PATIENTS.	AGTR1 NOS3	4.39e-05	2	231	2	35307690
Pubmed	Contributions of Asn2198, Met2199, and Phe2200 in the factor VIII C2 domain to cofactor activity, phospholipid-binding, and von Willebrand factor-binding.	F8 VWF	4.39e-05	2	231	2	12719775
Pubmed	Engineering the Ovarian Hormones Inhibin A and Inhibin B to Enhance Synthesis and Activity.	INHA INHBA	4.39e-05	2	231	2	32569368
Pubmed	Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.	F8 VWF	4.39e-05	2	231	2	16823491
Pubmed	Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.	F8 VWF	4.39e-05	2	231	2	37726033
Pubmed	Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.	INHA INHBA	4.39e-05	2	231	2	12587530
Pubmed	A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function.	F8 VWF	4.39e-05	2	231	2	22855607
Pubmed	Sources of variation in factor VIII, von Willebrand factor and fibrinogen measurements: implications for detecting deficiencies and increased plasma levels.	F8 VWF	4.39e-05	2	231	2	20627205
Pubmed	Endothelial nitric oxide synthase and angiotensin II type 1 receptor gene polymorphisms can influence chronic inflammatory state in renal transplant patients.	AGTR1 NOS3	4.39e-05	2	231	2	15848528
Pubmed	A Multi-Omics Approach Using a Mouse Model of Cardiac Malformations for Prioritization of Human Congenital Heart Disease Contributing Genes.	NOS3 NOTCH1	4.39e-05	2	231	2	34504875
Pubmed	Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.	F8 VWF	4.39e-05	2	231	2	27749002
Pubmed	Association study of AGO1 and AGO2 genes polymorphisms with recurrent pregnancy loss.	AGO2 AGO1	4.39e-05	2	231	2	31666609
Pubmed	Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase.	NOS3 XDH	4.39e-05	2	231	2	18818408
Pubmed	von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.	F8 VWF	4.39e-05	2	231	2	17119108
Pubmed	Expanding the phenotype in Adams-Oliver syndrome correlating with the genotype.	DOCK6 NOTCH1	4.39e-05	2	231	2	31654484
Pubmed	Low shear stress induces endothelial reactive oxygen species via the AT1R/eNOS/NO pathway.	AGTR1 NOS3	4.39e-05	2	231	2	28518223
Pubmed	Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins.	AGO2 AGO1	4.39e-05	2	231	2	23019594
Pubmed	Inhibition of microtubules and dynein rescues human immunodeficiency virus type 1 from owl monkey TRIMCyp-mediated restriction in a cellular context-specific fashion.	DYNC1H1 DYNC2H1	4.39e-05	2	231	2	25502651
Pubmed	Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells.	F8 VWF	4.39e-05	2	231	2	16953272
Pubmed	Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.	F8 VWF	4.39e-05	2	231	2	16953269
Pubmed	Thermodynamic analysis of the interaction of factor VIII with von Willebrand factor.	F8 VWF	4.39e-05	2	231	2	22559004
Pubmed	Factor VIII deficiency not induced by FVIII gene mutation in a female first cousin of two brothers with haemophilia A.	F8 VWF	4.39e-05	2	231	2	12406074
Pubmed	Von Willebrand Factor and Factor VIII levels in Egyptian children with newly diagnosed acute lymphoblastic leukemia in relation to peripheral blast cells and steroid therapy.	F8 VWF	4.39e-05	2	231	2	25105915
Pubmed	Absence of prostacyclin greatly relieves cyclophosphamide-induced cystitis and bladder pain in mice.	PTGIS PTGES	4.39e-05	2	231	2	34555210
Pubmed	Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2.	DSE DSEL	4.39e-05	2	231	2	16505484
Pubmed	Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.	AGO2 AGO1	4.39e-05	2	231	2	12230974
Pubmed	Cross-talk between Arg methylation and Ser phosphorylation modulates apoptosis signal-regulating kinase 1 activation in endothelial cells.	MAP3K5 PRMT5	4.39e-05	2	231	2	26912789
Pubmed	HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism.	HSPA12B NOS3	4.39e-05	2	231	2	23729663
Pubmed	The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.	F8 VWF	4.39e-05	2	231	2	25955153
Pubmed	Biological functions of iduronic acid in chondroitin/dermatan sulfate.	DSE DSEL	4.39e-05	2	231	2	23441919
Pubmed	Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells.	AGO2 AGO1	4.39e-05	2	231	2	21846468
Pubmed	Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.	F8 VWF	4.39e-05	2	231	2	27587878
Pubmed	Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1.	PTGIS PTGES	4.39e-05	2	231	2	26611322
Pubmed	High levels of IL-7 cause dysregulation of thymocyte development.	NOTCH1 IL7	4.39e-05	2	231	2	22899673
Pubmed	Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer.	NOS3 MPO	4.39e-05	2	231	2	17259657
Pubmed	Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.	INHA INHBA	4.39e-05	2	231	2	15950648
Pubmed	A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.	F8 VWF	4.39e-05	2	231	2	38320121
Cytoband	11q12.1	OR5M10 OR5M1 OR10V1 FADS2B OR8J2 OR1S2 OR9Q2 OR5A1 OR5AK3P OR8J1	1.07e-08	161	231	10	11q12.1
Cytoband	Ensembl 112 genes in cytogenetic band chr11q12	OR5M10 OR5M1 OR10V1 FADS2B OR8J2 OR1S2 OR9Q2 OR5A1 OR5AK3P OR8J1	1.14e-05	345	231	10	chr11q12
Cytoband	Ensembl 112 genes in cytogenetic band chr2p23	DNAJC27 CAPN13 OTOF DNMT3A XDH SELENOI	1.15e-04	149	231	6	chr2p23
GeneFamily	Cytochrome P450 family 8	CYP8B1 PTGIS	7.59e-05	2	158	2	1006
GeneFamily	O-linked N-acetylglucosaminyltransferases\|Tetratricopeptide repeat domain containing	OGT POMGNT2	4.50e-04	4	158	2	446
GeneFamily	Olfactory receptors, family 5	OR5M10 OR5M1 OR5C1 OR5A1 OR5AK3P OR5H8	4.52e-04	112	158	6	152
GeneFamily	Olfactory receptors, family 2	OR2A7 OR2W1 OR2AT4 OR2A4 OR2S2 OR2C1	4.74e-04	113	158	6	149
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A INHBA PTGIS F8 PPM1H CCDC3 PCDH15 NOS3 VWF TMTC1 HMCN1 ART4	3.11e-10	189	229	12	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	INHBA PTGIS F8 PPM1H PCDH15 DOCK6 NOS3 VWF TMTC1 HMCN1 ART4	3.87e-09	187	229	11	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYTL2 RAP1GAP2 DAPK1 DNAH14 PPM1H CFAP221 UGT8 KCP DNAH7 SPAG17 HYDIN	4.57e-09	190	229	11	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DAPK1 DNAH14 CFAP221 UGT8 KCP FHOD3 DNAH7 ARHGAP6 PACRG SPAG17 HYDIN	5.68e-09	194	229	11	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAP1GAP2 DAPK1 DNAH14 PPM1H CFAP221 UGT8 KCP FHOD3 DNAH7 ARHGAP6 HYDIN	6.32e-09	196	229	11	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCC4 PDE3A HSPA12B PTGIS DOCK6 NOS3 VWF TMTC1 HMCN1 BRINP2	2.11e-08	171	229	10	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	INHBA DAPK1 PTGIS F8 PCDH15 NOS3 VWF TMTC1 HMCN1 ART4	5.45e-08	189	229	10	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	INHBA DAPK1 PTGIS F8 PPM1H PCDH15 DOCK6 VWF TMTC1 HMCN1	5.45e-08	189	229	10	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	INHBA DAPK1 PTGIS F8 PPM1H PCDH15 VWF TMTC1 HMCN1 ART4	6.64e-08	193	229	10	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SYTL2 RAP1GAP2 DAPK1 PPM1H GLDC CFAP221 PITPNM2 KCP DNAH7	6.64e-08	193	229	10	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SYTL2 RAP1GAP2 DAPK1 PPM1H GLDC CFAP221 PITPNM2 KCP DNAH7	6.64e-08	193	229	10	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A PTGIS TRANK1 CCDC3 COL6A3 COL15A1 GRID2 TMTC1 ART4 TNXB	6.97e-08	194	229	10	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAP1GAP2 DAPK1 DNAH14 CFAP221 UGT8 KCP FHOD3 DNAH7 ARHGAP6 CRYL1	7.67e-08	196	229	10	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B TM6SF1 PTGIS F8 CCDC3 NOS3 VWF SEMA3D TMTC1 TNXB	8.84e-08	199	229	10	33f1669eeb701986b4dec409efdb6c06c3c41c2b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRINP3 COL6A3 COL15A1 APOB HMCN1 HECTD2 LRP4 LGR6 TNXB	4.31e-07	181	229	9	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A FRMPD4 TM6SF1 PTGIS FZD6 NOS3 VWF TMTC1 HMCN1	5.42e-07	186	229	9	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	Endothelial-A-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	HSPA12B PTGIS F8 CCDC3 FGF12 NOS3 VWF TMTC1 ART4	5.67e-07	187	229	9	fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A MYO1E PARVB HSPA12B TM6SF1 NOS3 VWF TMTC1 HMCN1	6.19e-07	189	229	9	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYTL2 RAP1GAP2 DAPK1 PPM1H CFAP221 UGT8 KCP DNAH7 SPAG17	6.76e-07	191	229	9	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYTL2 RAP1GAP2 DAPK1 PPM1H CFAP221 UGT8 KCP DNAH7 SPAG17	6.76e-07	191	229	9	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A CCDC3 PCDH15 FHOD3 GRID2 SEMA3D LRP4 LGR6 TNXB	6.76e-07	191	229	9	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A FRMPD4 CCDC3 PCDH15 COL6A3 PTGES GRID2 ARHGAP6 SEMA3D	7.07e-07	192	229	9	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	INHBA DAPK1 PTGIS F8 PCDH15 VWF TMTC1 HMCN1 ART4	7.38e-07	193	229	9	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 SYTL2 RAP1GAP2 DAPK1 PPM1H CFAP221 KCP DNAH7 HYDIN	7.70e-07	194	229	9	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RAP1GAP2 DAPK1 DNAH14 PPM1H CFAP221 UGT8 FHOD3 DNAH7 ARHGAP6	8.04e-07	195	229	9	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A PTGIS CCDC3 COL6A3 COL15A1 GRID2 TMTC1 ART4 TNXB	8.04e-07	195	229	9	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A HSPA12B TM6SF1 PTGIS F8 NOS3 VWF TMTC1 ART4	8.39e-07	196	229	9	915e4a7422058be246b54760df31e8a607310625
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B TM6SF1 CPT1C CCDC3 NOS3 NOTCH1 VWF TMTC1 TNXB	8.39e-07	196	229	9	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	10x3'2.3-week_12-13-Hematopoietic\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ABCC4 PDE3A PARVB UROD SMOX RHAG TFR2 ARHGAP6 ART4	8.39e-07	196	229	9	05b437af66cb43ba098ea93a02dc2f7430bf8c1b
ToppCell	Mesenchymal_cells-Fibro/Chondro_p.\|World / Lineage and Cell class	INHBA PTGIS GLDC CCDC3 PLOD2 COL6A3 COL15A1 SEMA3D LGR6	8.39e-07	196	229	9	ddc168849e0e97005a111be004463bb72d433853
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PARVB HSPA12B CCDC3 NOS3 VWF SEMA3D TMTC1 HMCN1 TNXB	8.39e-07	196	229	9	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PARVB HSPA12B CCDC3 NOS3 VWF SEMA3D TMTC1 HMCN1 TNXB	8.75e-07	197	229	9	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PARVB HSPA12B CCDC3 NOS3 VWF SEMA3D TMTC1 HMCN1 TNXB	8.75e-07	197	229	9	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP8B1 F8 DOCK6 VWF RHAG SEMA3D TMTC1 ART4 IL7	9.13e-07	198	229	9	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A PARVB PTGIS CCDC3 CARD6 NOS3 VWF TMTC1 BRINP2	9.13e-07	198	229	9	88b4662be9cc933a402c52673fa5e00fa979c0db
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRINP3 PDE3A CCDC3 TACR2 PITPNM2 FHOD3 ARHGAP6 SEMA3D LGR6	9.13e-07	198	229	9	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP8B1 F8 DOCK6 VWF RHAG SEMA3D TMTC1 ART4 IL7	9.13e-07	198	229	9	b3a020522e064bb61949d38e442f24026e339364
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A PARVB HSPA12B TM6SF1 PTGIS F8 NOS3 VWF TMTC1	9.13e-07	198	229	9	002424b24dacac553e02d0f764a6e8a1e567b9df
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	PDE3A INHBA PTGIS AGTR1 COL6A3 COL15A1 REV3L TMTC1 ART4	9.52e-07	199	229	9	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDE3A PARVB HSPA12B FZD6 DOCK6 NOS3 VWF TMTC1 HMCN1	9.93e-07	200	229	9	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D122\|Adult / Lineage, Cell type, age group and donor	PDE3A HSPA12B PTGIS F8 NOS3 VWF TMTC1 HMCN1	2.63e-06	168	229	8	8c3e1e45b422813bcdfa4273b1167db649a312f5
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	BCKDHA ABCB4 PITPNM2 VWF COL15A1 XDH TFR2 GYS2	3.00e-06	171	229	8	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	droplet-Spleen-SPLEEN-30m-Hematologic-erythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSF ABCB4 UBE2B UROD SMOX MPO RHAG ART4	3.27e-06	173	229	8	a8fb8db6061fa4d8d56a7b45004ecbd344501573
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGO2 F8 GLDC SMOX C17orf58 RUBCN ANKRD7	3.48e-06	123	229	7	a45d6907c041ad3f3218cd46dccfc25d4bd961cb
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3A INHA AGTR1 SMOX PLOD2 VWF RHAG ARHGAP6	4.21e-06	179	229	8	4e0cf069bc47328eda753a4edc7e89b8915d52bb
ToppCell	droplet-Spleen-nan-24m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSF ABCB4 UROD SMOX ABCB6 RHAG TFR2 ART4	4.21e-06	179	229	8	f3f9c7e575bc4d9d3bce649b90254182e8f6aaec
ToppCell	droplet-Spleen-nan-24m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSF ABCB4 UROD SMOX ABCB6 RHAG TFR2 ART4	4.21e-06	179	229	8	01e0b49e7f03ac9c3e6c34708ead300d27236b8b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ADGRV1 TRANK1 PCDH15 APOB HMCN1 SPAG17 HYDIN	5.16e-06	184	229	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ADGRV1 TRANK1 PCDH15 APOB HMCN1 SPAG17 HYDIN	5.16e-06	184	229	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 ADGRV1 TRANK1 PCDH15 APOB HMCN1 SPAG17 HYDIN	5.16e-06	184	229	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	PDE3A HSPA12B PTGIS F8 NOS3 VWF TMTC1 HMCN1	5.59e-06	186	229	8	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A INHBA AGTR1 COL6A3 COL15A1 REV3L TMTC1 ART4	5.81e-06	187	229	8	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	10x5'v1-week_17-19-Hematopoietic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PDE3A PARVB UROD RHAG TFR2 ARHGAP6 GYS2 IL7	6.05e-06	188	229	8	c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	CYP8B1 F8 DOCK6 SEMA3D TMTC1 ART4 TNXB IL7	6.05e-06	188	229	8	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP8B1 F8 DOCK6 SEMA3D TMTC1 ART4 TNXB IL7	6.05e-06	188	229	8	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A FRMPD4 CCDC3 PCDH15 COL6A3 PTGES ARHGAP6 SEMA3D	6.29e-06	189	229	8	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	PDE3A HSPA12B PTGIS F8 NOS3 VWF TMTC1 HMCN1	6.29e-06	189	229	8	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Tac2_(Substantia_Innominata_(SI),_dorsal,_bordering_GP)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	GNRHR MPO CCDC185 ENAM GYS2	6.35e-06	51	229	5	138c64f5f338ee82b04b03d827a3c8e997e5c9e4
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Tac2_(Substantia_Innominata_(SI),_dorsal,_bordering_GP)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	GNRHR MPO CCDC185 ENAM GYS2	6.35e-06	51	229	5	56f500e6e6735f4df1f6709f4cf4b200d70c7093
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Tac2_(Substantia_Innominata_(SI),_dorsal,_bordering_GP)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	GNRHR MPO CCDC185 ENAM GYS2	6.35e-06	51	229	5	050f8eee8378dadd556e18e7d8c8aa5437d184bf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A HSPA12B TM6SF1 PTGIS F8 CCDC3 VWF TMTC1	6.53e-06	190	229	8	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A PTGIS TRANK1 COL6A3 COL15A1 GRID2 TMTC1 TNXB	6.53e-06	190	229	8	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A MAP3K5 CCDC3 PCDH15 COL6A3 PTGES GRID2 REV3L	6.53e-06	190	229	8	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A FRMPD4 CCDC3 PCDH15 COL6A3 PTGES ARHGAP6 SEMA3D	6.53e-06	190	229	8	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A TM6SF1 PTGIS FZD6 NOS3 VWF TMTC1 HMCN1	6.53e-06	190	229	8	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	CYP8B1 F8 DOCK6 SEMA3D TMTC1 ART4 TNXB IL7	6.53e-06	190	229	8	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	INHBA DAPK1 PTGIS PPM1H PCDH15 VWF HMCN1 ART4	7.05e-06	192	229	8	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A FRMPD4 CCDC3 PCDH15 COL6A3 PTGES ARHGAP6 SEMA3D	7.05e-06	192	229	8	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A HSPA12B TM6SF1 PTGIS CCDC3 NOS3 VWF TMTC1	7.33e-06	193	229	8	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CATSPERD CFAP221 DYNC2H1 DNAH7 PACRG SPAG17 HYDIN IL7	7.33e-06	193	229	8	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A CCDC3 PCDH15 COL6A3 PTGES GRID2 ARHGAP6 SEMA3D	7.61e-06	194	229	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	INHBA PTGIS PCDH15 NOS3 VWF TMTC1 HMCN1 ART4	7.61e-06	194	229	8	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A FRMPD4 CCDC3 PCDH15 COL6A3 GRID2 ARHGAP6 SEMA3D	7.61e-06	194	229	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A INHBA MAP3K5 AGTR1 COL15A1 REV3L TMTC1 TNXB	7.90e-06	195	229	8	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A INHBA PTGIS CCDC3 COL6A3 COL15A1 TMTC1 TNXB	7.90e-06	195	229	8	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A INHBA PLOD2 COL6A3 COL15A1 REV3L TMTC1 ART4	7.90e-06	195	229	8	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A INHBA MAP3K5 AGTR1 COL15A1 REV3L TMTC1 TNXB	7.90e-06	195	229	8	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl_(Layer_2/3)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TDRD9 CYP8B1 OTOP2 OTOF MPO ANKRD7	8.06e-06	92	229	6	dfe63bb979f0382163955b32909ffab1de37685a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A MAP3K5 AGTR1 COL6A3 COL15A1 REV3L TMTC1 TNXB	8.20e-06	196	229	8	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A INHBA PTGIS CCDC3 COL6A3 COL15A1 HMCN1 TNXB	8.20e-06	196	229	8	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A INHBA PTGIS CCDC3 COL6A3 COL15A1 HMCN1 TNXB	8.20e-06	196	229	8	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYTL2 DAPK1 PPM1H CFAP221 FHOD3 DNAH7 ARHGAP6 HYDIN	8.51e-06	197	229	8	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B DOCK6 NOS3 VWF COL15A1 SEMA3D TMTC1 TNXB	8.51e-06	197	229	8	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A INHBA AGTR1 COL6A3 COL15A1 TMTC1 ART4 TNXB	8.51e-06	197	229	8	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A INHBA AGTR1 COL6A3 COL15A1 TMTC1 ART4 TNXB	8.51e-06	197	229	8	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PARVB HSPA12B TM6SF1 PTGIS NOS3 VWF TMTC1 ART4	8.51e-06	197	229	8	b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B DOCK6 NOS3 VWF COL15A1 SEMA3D TMTC1 TNXB	8.51e-06	197	229	8	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HSPA12B F8 DOCK6 NOS3 PPEF2 SEMA3D ART4 IL7	8.83e-06	198	229	8	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	Endothelial_cells\|World / lung cells shred on cell class, cell subclass, sample id	HSPA12B PTGIS F8 NOS3 VWF TMTC1 ART4 TNXB	8.83e-06	198	229	8	b93effa428ec036542fa21647dfef9589c64640f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B PTGIS F8 NOS3 VWF SEMA3D TMTC1 TNXB	8.83e-06	198	229	8	259fbcc0f2ac281a3e4d693de45b986fe5e24841
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B TM6SF1 PTGIS CCDC3 NOS3 SEMA3D TMTC1 TNXB	8.83e-06	198	229	8	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HSPA12B F8 DOCK6 NOS3 PPEF2 SEMA3D ART4 IL7	8.83e-06	198	229	8	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRINP3 PDE3A CCDC3 TACR2 PITPNM2 FHOD3 SEMA3D LGR6	8.83e-06	198	229	8	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	PDE3A PTGIS CCDC3 COL6A3 FHOD3 ARHGAP6 HMCN1 TNXB	8.83e-06	198	229	8	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PARVB HSPA12B TM6SF1 PTGIS NOS3 VWF TMTC1 ART4	9.16e-06	199	229	8	3a4deea6e11a0555d27497b7c9983350797aac69
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PARVB HSPA12B PTGIS F8 DOCK6 NOS3 VWF TMTC1	9.16e-06	199	229	8	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B PTGIS CCDC3 NOS3 VWF SEMA3D TMTC1 TNXB	9.16e-06	199	229	8	f35e9c05d0a0339ff691b38564da7aad8e9218aa
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B TM6SF1 PTGIS CCDC3 NOS3 VWF TMTC1 TNXB	9.16e-06	199	229	8	a3ec743b978ba8fdf1677b4971b5731f50ddd30f
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PARVB HSPA12B PTGIS F8 DOCK6 NOS3 VWF TMTC1	9.16e-06	199	229	8	d58edc5f74970bb26d844746184e4bae7c494d6b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPA12B F8 DOCK6 NOS3 VWF COL15A1 TMTC1 TNXB	9.50e-06	200	229	8	b1be27d134a8633e3e7862c6a0d7be2001d387f0
Disease	cerebral infarction (is_marker_for)	BRINP3 ITGAM APOB SOS1	1.07e-05	19	220	4	DOID:3526 (is_marker_for)
Disease	Essential hypertension, genetic	PTGIS AGTR1 NOS3	4.72e-05	10	220	3	cv:CN305331
Disease	Essential hypertension	PTGIS AGTR1 NOS3	4.72e-05	10	220	3	cv:C0085580
Disease	HYPERTENSION, ESSENTIAL	PTGIS AGTR1 NOS3	4.72e-05	10	220	3	145500
Disease	von Willebrand's disease 2 (is_marker_for)	F8 VWF	5.53e-05	2	220	2	DOID:0060574 (is_marker_for)
Disease	Essential Hypertension	PTGIS AGTR1 NOS3	8.56e-05	12	220	3	C0085580
Disease	brain ischemia (implicated_via_orthology)	PTGIS LONP1 NOS3 SOS1	1.31e-04	35	220	4	DOID:2316 (implicated_via_orthology)
Disease	Cardiovascular Diseases	NOS3 MPO VWF APOB	1.47e-04	36	220	4	C0007222
Disease	essential hypertension (is_implicated_in)	PTGIS AGTR1 NOS3	3.07e-04	18	220	3	DOID:10825 (is_implicated_in)
Disease	vasculitis (is_implicated_in)	NOS3 MPO	3.29e-04	4	220	2	DOID:865 (is_implicated_in)
Disease	Alzheimer disease type 1	NOS3 MPO	3.29e-04	4	220	2	cv:C1863052
Disease	ALZHEIMER DISEASE, FAMILIAL, 1	NOS3 MPO	3.29e-04	4	220	2	104300
Disease	cholestasis (biomarker_via_orthology)	ABCC4 ABCB4 NOS3 XDH	4.90e-04	49	220	4	DOID:13580 (biomarker_via_orthology)
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	BSND NUDT12 PELO DDX56 APOB TFR2	5.86e-04	137	220	6	EFO_0004611, EFO_0008591
Disease	hypertrophic cardiomyopathy	FADS2B KCP AMBRA1 OR5AK3P FHOD3	6.40e-04	92	220	5	EFO_0000538
Disease	pulmonary hypertension (implicated_via_orthology)	CYSLTR1 PTGIS TACR2 NOS3	7.10e-04	54	220	4	DOID:6432 (implicated_via_orthology)
Disease	Congenital defect of skull and scalp	DOCK6 NOTCH1	8.14e-04	6	220	2	C2931779
Disease	amphetamine abuse (implicated_via_orthology)	MAP3K5 SLC18A1	8.14e-04	6	220	2	DOID:670 (implicated_via_orthology)
Disease	familial combined hyperlipidemia (is_marker_for)	VWF APOB	8.14e-04	6	220	2	DOID:13809 (is_marker_for)
Disease	Adams Oliver syndrome	DOCK6 NOTCH1	8.14e-04	6	220	2	C0265268
Disease	Patent Ductus Arteriosus Familial	PTGIS AGTR1	8.14e-04	6	220	2	C2936170
Disease	Adams-Oliver syndrome 1	DOCK6 NOTCH1	8.14e-04	6	220	2	C4551482
Disease	congenital muscular dystrophy (implicated_via_orthology)	DYNC1H1 COL6A3	8.14e-04	6	220	2	DOID:0050557 (implicated_via_orthology)
Disease	Patent ductus arteriosus	PTGIS AGTR1	8.14e-04	6	220	2	C0013274
Disease	Adams-Oliver syndrome (is_implicated_in)	DOCK6 NOTCH1	8.14e-04	6	220	2	DOID:0060227 (is_implicated_in)
Disease	REM sleep behavior disorder	INPP5F SCARB2	8.14e-04	6	220	2	EFO_0007462
Disease	myeloperoxidase measurement	MPO THADA TNXB	9.37e-04	26	220	3	EFO_0005243
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	TOMM40L APOB SLC18A1 LRP4 SELENOI	1.07e-03	103	220	5	EFO_0008595, EFO_0020944
Disease	neutropenia (implicated_via_orthology)	ITGAM C5	1.13e-03	7	220	2	DOID:1227 (implicated_via_orthology)
Disease	Early-onset autosomal dominant Alzheimer disease	NOS3 MPO	1.13e-03	7	220	2	cv:CN043596
Disease	Albinism, Oculocutaneous	HPS1 OCA2	1.13e-03	7	220	2	C0078918
Disease	Early Pregnancy Loss	INHA LGALS14 PTGIS AGTR1 COL6A3	1.37e-03	109	220	5	C3830362
Disease	Spontaneous abortion	INHA LGALS14 PTGIS AGTR1 COL6A3	1.37e-03	109	220	5	C0000786
Disease	Miscarriage	INHA LGALS14 PTGIS AGTR1 COL6A3	1.37e-03	109	220	5	C4552766
Disease	Abortion, Tubal	INHA LGALS14 PTGIS AGTR1 COL6A3	1.37e-03	109	220	5	C0000822
Disease	Heart Decompensation	ACLY AGTR1 NOS3 VWF XDH	1.43e-03	110	220	5	C1961112
Disease	Myocardial Failure	ACLY AGTR1 NOS3 VWF XDH	1.43e-03	110	220	5	C1959583
Disease	Congestive heart failure	ACLY AGTR1 NOS3 VWF XDH	1.43e-03	110	220	5	C0018802
Disease	Heart failure	ACLY AGTR1 NOS3 VWF XDH	1.43e-03	110	220	5	C0018801
Disease	Left-Sided Heart Failure	ACLY AGTR1 NOS3 VWF XDH	1.43e-03	110	220	5	C0023212
Disease	Heart Failure, Right-Sided	ACLY AGTR1 NOS3 VWF XDH	1.43e-03	110	220	5	C0235527
Disease	pulmonary hypertension (is_implicated_in)	AGTR1 NOS3 VWF	1.43e-03	30	220	3	DOID:6432 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	PDE3A ITGAM BSND PELO PITPNM2 APOB SLC18A1	1.44e-03	222	220	7	EFO_0008317, EFO_0020943
Disease	coronary artery disease, factor VII measurement	NBEAL1 NOS3 ITCH DYNC2H1 APOB	1.49e-03	111	220	5	EFO_0001645, EFO_0004619
Disease	Primary sclerosing cholangitis	ABCB4 GPR35	1.50e-03	8	220	2	C0566602
Disease	Alzheimer disease	NOS3 MPO	1.50e-03	8	220	2	cv:C0002395
Disease	response to tenofovir, creatinine clearance measurement	OR5M10 OR5M1 FHOD3 GRID2 EYS	1.55e-03	112	220	5	EFO_0007934, EFO_0009279
Disease	factor VIII measurement, coronary artery disease	NBEAL1 NOS3 VWF DYNC2H1 APOB	1.61e-03	113	220	5	EFO_0001645, EFO_0004630
Disease	retinal degeneration (implicated_via_orthology)	NOS3 SCO2 EYS	1.89e-03	33	220	3	DOID:8466 (implicated_via_orthology)
Disease	cystic fibrosis (implicated_via_orthology)	ABCC4 ABCB4	1.92e-03	9	220	2	DOID:1485 (implicated_via_orthology)
Disease	von Willebrand factor measurement, coronary artery disease	NBEAL1 NOS3 VWF DYNC2H1 APOB	1.95e-03	118	220	5	EFO_0001645, EFO_0004629
Disease	Spinocerebellar Ataxia Type 2	CIC GRID2 RUBCN	2.06e-03	34	220	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	CIC GRID2 RUBCN	2.06e-03	34	220	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	CIC GRID2 RUBCN	2.06e-03	34	220	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	CIC GRID2 RUBCN	2.06e-03	34	220	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	CIC GRID2 RUBCN	2.06e-03	34	220	3	C0752124
Disease	Ataxia, Spinocerebellar	CIC GRID2 RUBCN	2.06e-03	34	220	3	C0087012
Disease	Spinocerebellar Ataxia Type 4	CIC GRID2 RUBCN	2.24e-03	35	220	3	C0752122
Disease	hip bone mineral density, age at menarche	PCDH15 RHAG	2.39e-03	10	220	2	EFO_0004703, EFO_0007702
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma	AGO2 DAPK1 UGT8	3.07e-03	39	220	3	EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354
Disease	monocyte measurement	TM6SF1 MPO GPR35 THADA	3.34e-03	82	220	4	EFO_0803547
Disease	mitochondrial DNA measurement	CATSPERD BSND NUDT12 LONP1 SCO2 VWF TWNK THADA	3.36e-03	328	220	8	EFO_0006312
Disease	chronic kidney disease (implicated_via_orthology)	AGTR1 XDH	3.48e-03	12	220	2	DOID:784 (implicated_via_orthology)
Disease	microphthalmia (implicated_via_orthology)	CRYBA1 ARHGAP6	3.48e-03	12	220	2	DOID:10629 (implicated_via_orthology)
Disease	end stage renal disease (is_implicated_in)	NOS3 MPO VWF	3.54e-03	41	220	3	DOID:783 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	BSND PELO PITPNM2 DDX56 APOB SLC18A1 LRP4	3.80e-03	264	220	7	EFO_0008317, EFO_0020944
Disease	liver cirrhosis (is_implicated_in)	ABCB4 C5 MPO	4.05e-03	43	220	3	DOID:5082 (is_implicated_in)
Disease	intermediate coronary syndrome (is_marker_for)	ITGAM AGTR1	4.09e-03	13	220	2	DOID:8805 (is_marker_for)
Disease	thyroid peroxidase antibody measurement, anti-thyroglobulin antibody measurement	TRPM6 NUDT12 ANKRD7	4.61e-03	45	220	3	EFO_0005666, EFO_0009896
Disease	chronic kidney disease (is_implicated_in)	AGTR1 XDH	4.75e-03	14	220	2	DOID:784 (is_implicated_in)
Disease	response to beta blocker, mortality	NUDT12 TMTC1	4.75e-03	14	220	2	EFO_0004352, EFO_0007766
Disease	unipolar depression, information processing speed, cognitive function measurement	PDE3A PCDH15 MPO	5.21e-03	47	220	3	EFO_0003761, EFO_0004363, EFO_0008354
Disease	acute graft vs. host disease, donor genotype effect measurement	EYS TMEM131	5.45e-03	15	220	2	EFO_0004599, EFO_0007892
Disease	Proteinuria	VWF CRYL1	5.45e-03	15	220	2	HP_0000093
Disease	amenorrhea, response to antineoplastic agent	APOB TMTC1	5.45e-03	15	220	2	EFO_0010269, GO_0097327
Disease	total lipids in lipoprotein particles measurement	BSND DOCK6 APOB	5.52e-03	48	220	3	EFO_0022309
Disease	phosphatidylinositol measurement	FGF12 DOCK6 APOB SCARB2	5.64e-03	95	220	4	EFO_0010230
Disease	Neoplasm Metastasis	ABCC4 DAPK1 CIC AGTR1 NAGK SLC39A4	5.91e-03	217	220	6	C0027627
Disease	pulmonary fibrosis (biomarker_via_orthology)	CYSLTR1 NOTCH1 VWF	6.19e-03	50	220	3	DOID:3770 (biomarker_via_orthology)
Disease	syndromic intellectual disability (implicated_via_orthology)	UBE2A UBE2B	6.20e-03	16	220	2	DOID:0050888 (implicated_via_orthology)
Disease	Myasthenic Syndromes, Congenital, Slow Channel	CHRNG LRP4	6.20e-03	16	220	2	C0751885
Disease	Pre-Eclampsia	INHBA NOS3	6.20e-03	16	220	2	C0032914
Disease	sickle cell anemia (is_implicated_in)	NOS3 APOB	6.20e-03	16	220	2	DOID:10923 (is_implicated_in)
Disease	hearing impairment	ADGRV1 BSND OTOF PCDH15	6.29e-03	98	220	4	C1384666
Disease	asthma (is_implicated_in)	CYSLTR1 TACR2 C5 NOS3 MPO	6.57e-03	157	220	5	DOID:2841 (is_implicated_in)
Disease	severe acute respiratory syndrome, COVID-19	FRMPD4 CATSPERD RAP1GAP2 GLDC COL6A3 TG ARHGAP6 EYS SELENOI	6.65e-03	447	220	9	EFO_0000694, MONDO_0100096
Disease	Colorectal Carcinoma	ABCC4 OTOP2 ABCB4 TOMM40L MPO POLE ABCB6 GRID2 APOB LGR6 DSEL SPAG17	6.73e-03	702	220	12	C0009402
Disease	coronary artery disease (is_implicated_in)	BRINP3 AGTR1 NOS3 APOB	6.75e-03	100	220	4	DOID:3393 (is_implicated_in)
Disease	Malignant neoplasm of breast	CIC PER3 OTOF UTP20 SMOX NIPBL NOS3 NOTCH1 DNMT3A VWF DYNC2H1 UBR4 ABCB6 XDH OCA2 LGR6	6.96e-03	1074	220	16	C0006142
Disease	Congenital Myasthenic Syndromes, Postsynaptic	CHRNG LRP4	6.99e-03	17	220	2	C0751883
Disease	Necrotizing Enterocolitis	NOS3 CRYL1	6.99e-03	17	220	2	C0520459
Disease	Lipidemias	NOS3 APOB	6.99e-03	17	220	2	C1706412
Disease	extrahepatic cholestasis (biomarker_via_orthology)	ABCC4 CYP8B1	6.99e-03	17	220	2	DOID:13619 (biomarker_via_orthology)
Disease	Hyperlipidemia	NOS3 APOB	6.99e-03	17	220	2	C0020473
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	PDE3A ITGAM BSND DDX56 APOB SLC18A1	7.02e-03	225	220	6	EFO_0008317, EFO_0020947

Protein segments in the cluster

Peptide	Gene	Start	Entry
YMFFHVRFINPDLLV	TMCO5A	241	Q8N6Q1
MAGFSHFSQPPYRDL	CCDC185	1	Q8N715
HEPVMIYQPRDFFRA	DAPK1	1246	P53355
IQVFGYSMHFDPEAI	BRINP3	666	Q76B58
QFEGLLRPYIQHAMY	BTNL3	436	Q6UXE8
MFKYSDHPLNRSFGL	CATSPERD	221	Q86XM0
RVFGFPVHYTDVSNM	DNMT3A	866	Q9Y6K1
IFLMAHYNRVPALPF	CHRNG	491	P07510
AGRHNYIFVMIPTLY	AGTR1	21	P30556
SIPGIYFFTYHVLMR	C1QL3	166	Q5VWW1
GIPYHDREANDMLIF	GYS2	141	P54840
EAKPHSRPYMAFVQF	GZMH	26	P20718
SPRYNITFMGLEKLH	HDAC11	21	Q96DB2
MDVYNRHIYPGDRFA	HDAC11	201	Q96DB2
LTELMFEHYNIPAFF	ACTL6A	136	O96019
HLASMRYTPVGRSFF	AGO1	166	Q9UL18
GLDYIFTPMILHFAD	ADGRV1	3006	Q8WXG9
FTPMILHFADGERYK	ADGRV1	3011	Q8WXG9
RMYPFQIHSIALSTF	CDS2	331	O95674
TPMLHAQVFVRDANY	DUS1L	46	Q6P1R4
HDAIMAFPEGYRTQV	ABCB6	706	Q9NP58
FRRNFTMTYHLSPGN	CAPN13	441	Q6MZZ7
MPFLHGFRRIIFEYQ	ASB6	1	Q9NWX5
LAPHNLGEMLYTKRF	AMBRA1	926	Q9C0C7
SAFFHEYLVSVPLRM	DGAT1	411	O75907
DFMGEAHPVVFSRYI	CAMSAP1	751	Q5T5Y3
FGLMRALPQNDDHYV	TNK2	271	Q07912
VEPMFRHLKNTYAGL	AGO2	501	Q9UKV8
RQVFDGLHMDPYDLT	AMPD3	356	Q01432
IYFLEERMQQEFHGP	CDK5RAP2	81	Q96SN8
TVINHYRMRGHSPFA	INHBA	371	P08476
QAMFHYFQVPDRLGI	NAGK	186	Q9UJ70
NSAGVMHYLIRVEPF	NBEAL1	2101	Q6ZS30
MFFLNSFVPGIHLDL	OCA2	636	Q04671
FPYEFFARQGIHDML	PACRG	121	Q96M98
QTPMYFFLGHLSFVD	OR5M10	56	Q6IEU7
MFADYRLPQVLAHLG	C9orf64	236	Q5T6V5
MILAVFFAQIHPNYL	PAQR3	181	Q6TCH7
HIPMYLFLGSLAFVD	OR5H8	56	P0DN80
HLMNSFGFPQYVKIF	ORC4	216	O43929
VKQMLDDFGPHRYIA	UROD	321	P06132
VNFGLPLGVFYRMHS	OTOP3	571	Q7RTS5
GDRRLHTPMYFFLSH	OR9Q2	51	Q8NGE9
YATVGPLVVYFAMHR	DNAJC11	391	Q9NVH1
HTPMYFFLANLAVLE	OR10V1	56	Q8NGI7
HTPMYFLLGNFAFLE	OR11H4	66	Q8NGC9
LDSRLHMPMYFFLGN	OR13C4	51	Q8NGS5
PAQLHFMYVAAAAFV	NOTCH1	1731	P46531
ASQAYFESMFLGHIP	EYS	2276	Q5T1H1
AYLFLMFHTGPRTAR	LPAR2	81	Q9HBW0
AVLSAFHEPRYMGIA	GPR179	566	Q6PRD1
AFMGNPLLQTIHFYD	LGR6	276	Q9HBX8
DMAGHPFFYEVRNEF	DNAJC27	71	Q9NZQ0
LYLTPDGFFFRVHML	C17orf58	246	Q2M2W7
AEMLAFHINASYPRI	KIAA1109	456	Q2LD37
LLLIRQIFHPDYGMF	HECTD2	466	Q5U5R9
HLPRIYQAFLMSATF	DDX56	186	Q9NY93
IDIGPARFQLQYMGH	DDX60L	711	Q5H9U9
RFQAMYTSHLFNLDP	ESF1	761	Q9H501
AVYEHVRMKGLNPFE	GRID2	686	O43424
HFVDLLAPQDMRVFY	PER3	166	P56645
MRVFYAHTARAQLPF	PER3	176	P56645
TLDVHLQTPMYFFLR	OR14L1P	51	Q8NHC6
IFYVPFIGLSMVHRF	OR51E1	251	Q8TCB6
LDSQLHTPMYFFLRN	OR2W1	51	Q9Y3N9
QQSLHEPMYYFLFRL	OR51F1	61	A6NGY5
FGEHLPRVVHLFMSY	OR51G1	266	Q8NGK1
HSPMYFLLGNLSFVD	OR4K5	56	Q8NGD3
LIRGDTHLHTPMYFF	OR5A1	51	Q8NGJ0
PIREFMNYFHALEIG	PDE3A	731	Q14432
MNYFHALEIGYRDIP	PDE3A	736	Q14432
RAVVVGFDPHFSYMK	PGP	166	A6NDG6
NAFRYGHTLIQPFMF	MPO	496	P05164
LGFAFIQHPSLMFEQ	NIPBL	2196	Q6KC79
PSFARLGQMVLEYDH	NCKAP1L	171	P55160
MRTHTRGAPSVFFIY	DSE	1	Q9UL01
IAYTFARAFLMQHAP	LONP1	816	P36776
LGPLFRNSRMVQFHF	MED25	461	Q71SY5
PYFNIRDIYAQRMHT	KCNS3	436	Q9BQ31
RFHAINGYIMDTLPG	F8	1936	P00451
AFEMSRYFHIPIGNL	POLE	1646	Q07864
DRFEDLPLYFMTFHG	TWNK	476	Q96RR1
LPLYFMTFHGQQSIR	TWNK	481	Q96RR1
QFPGLAHEARLFFME	POMGNT2	181	Q8NAT1
APMYFFLSHLAVVDI	OR2A7	56	Q96R45
ILDSRLHTPMYFFLG	OR2S2	51	Q9NQN1
LEARLHTPMYFFLSN	OR2C1	51	O95371
DARLHTPMYFFLANL	OR5C1	56	Q8NGR4
FDTVMRVHYPSALGR	PITPNM2	456	Q9BZ72
TMPALEVFAHALRFF	HSPA12B	166	Q96MM6
TRHNFNSMAFPLLGF	GPR35	166	Q9HC97
DRFLNSFASMHRFGP	NDUFA9	211	Q16795
VHRPGFYAERFQRFM	PIP5K1A	431	Q99755
GVFMYISNRHEFGRL	PLOD2	501	O00469
HTVFYDQAQGRMPFL	HMCN1	5041	Q96RW7
FRFGAYLIVNGHMRF	ABCB4	956	P21439
LTPVFHQEMVNYFLS	NOS3	456	P29474
QTPMYFFPQHLAFVD	OR5AK3P	56	Q8NH89
HPLNYTTFMRARFGT	OR1S2	141	Q8NGQ3
APMYFFLSHLAVVDI	OR2A4	56	O95047
LMGLLEDYFVPLHHF	PARVB	291	Q9HBI1
IVNICLPFGIFYRMH	OTOP2	536	Q7RTS6
LPFGIFYRMHAVSSL	OTOP2	541	Q7RTS6
LHYVNKPMLRAFGDI	FADS2B	451	A8MWK0
EAALHQPMYYFLGIL	OR56B2P	61	Q8NGI1
QTPMYFFLRHLAIIN	OR8J2	56	Q8NGG1
LYRVPGQFMLVGHLS	ARHGAP6	696	O43182
PHEGVIIFDNVNFMY	ABCC4	1036	O15439
MRFTVDGIPYFVDHN	ITCH	486	Q96J02
ILVGTPEDYPRFFHM	PCDH15	326	Q96QU1
VDSRLQTPMYFFLQH	OR8J1	51	Q8NGP2
IFSGRHPMLFSYQRS	CPT1C	156	Q8TCG5
FFPNLMGHYDQSIAA	FZD6	41	O60353
FALHFVRGMHPELFQ	DYNC2H1	3571	Q8NCM8
FMPQGAVFSCLYRHA	GLG1	586	Q92896
FLHYIFMENAFELPT	APOB	826	P04114
ISHIFIPAMGNITYD	APOB	3326	P04114
TGQARFAHGMFTVYP	HYDIN	3256	Q4G0P3
LGTFLMSHDRPQVYG	BSND	21	Q8WZ55
QSFHPQIFYSGERFM	CARD6	786	Q9BX69
MFELSGPFRQQHFLA	DOCK6	1096	Q96HP0
MVHFILGRLYNFQPF	SDR42E1	296	Q8WUS8
AGPQLYIFRMIHLAD	GNRHR	171	P30968
LPNEGRNDYHPMFFT	ELMO2	426	Q96JJ3
FFFLRMDENYNLLPH	CCDC3	121	Q9BQI4
DGRDYFINHMTQAIP	FRMPD4	46	Q14CM0
EFPAAHDRMVYLGLS	BPI	276	P17213
RMPITYDNGFLFIHT	C5	116	P01031
GIPLFGDHYDTMTRV	UGT8	376	Q16880
LMHLEFGRGFMYDRP	COL6A3	1991	P12111
GSNAYHIERLMSFRP	CRYBA1	101	P05813
MGYRPIAIHSSILFF	DNAH7	3201	Q8WXX0
IINRFHSFLLFMGHP	FHOD3	1216	Q2V2M9
AFGMQFYRHGISRPL	CTSF	406	Q9UBX1
FISMVLLHRYPQFTA	ANKRD7	231	Q92527
AQFEMPYVVRLHNFH	PRMT5	496	O14744
PHYQMIAEIILFSFG	DNAH14	1266	Q0VDD8
MFHVSFRYIFGLPPL	IL7	1	P13232
AEEGLFRYMFRPSQH	INHA	106	P05111
LSDVFPGVQYHRGEM	DYNC1H1	2161	Q14204
GRTMAITPRHYLDFI	DYNC1H1	3166	Q14204
ELHPRVFYFMVGTAF	SELENOI	286	Q9C0D9
SVHDMDYVNPRGVRF	GBF1	371	Q92538
RYAFIGPLETMHLNA	CRYL1	231	Q9Y2S2
FTGTVMGHRQNRPFY	ENAM	336	Q9NRM1
IVARAHNGPVFAMYT	EML5	1596	Q05BV3
MVSYLEDFPGLVHFI	HPS1	531	Q92902
GQFNMHIPIYSFDGR	COL15A1	1296	P39059
LLPMYQEAEHGSFRV	RUBCN	551	Q92622
ASGYFHTLRAVMRNP	INPP5F	701	Q9Y2H2
AMARYVQDFHPRLLG	SCO2	176	O43819
LHPSLYFDAGEIQAM	DSEL	61	Q8IZU8
AIAADRYMAIVHPFQ	TACR2	126	P21452
GFGTMQPSHDVRFRY	CYP8B1	481	Q9UNU6
YLHVNIFQHIGLPMF	FADS6	241	Q8N9I5
MRPQVTDRNYFHLPY	OTOF	691	Q9HC10
FMLVYPKEFHLNRGN	PPEF2	226	O14830
NQPFLIEAMTYRIGH	BCKDHA	321	P12694
LAYMPHTFFIGDHAN	OGT	696	O15294
SSARLHTPMYFFLGN	OR10D3	51	Q8NH80
AYRADLPLDFHIMGN	OR2AT4	266	A6NND4
VIQVGMALHTPLYFF	OR6K6	76	Q8NGW6
PFIYSLRNKDMHGAL	OR1D2	286	P34982
VSPALHSPMYFFLRQ	OR10P1	51	Q8NGE3
HSPMYFFLRQLSVVE	OR10P1	56	Q8NGE3
RLHTPMYFFLGNLSF	OR13D1	86	Q8NGV5
IHAYPVMNSLDFPSF	CFAP221	151	Q4G0U5
MSDAFRQPSLFYHLG	MAP3K5	156	Q99683
RLFSQQGYFLQMHPD	FGF12	76	P61328
PIFNHTMVYDGFRPE	SYTL2	841	Q9HCH5
GYFMDHTVAFRDLPV	SARS2	306	Q9NP81
HLYIDIFDGMPRSKQ	TAF5	336	Q15542
LHIGPLASEQMFYAV	TMEM106A	181	Q96A25
SHDYPLFGNLVIMVS	TAAR3P	41	Q9P1P4
MIAYLFDTFPQGLLH	UTP20	2306	O75691
LLQAAAAFPMYGRVH	THADA	911	Q6YHU6
FVPDMIASNFLHAYI	RAP1GAP2	371	Q684P5
FAMPFRQHLDGYRNK	TDRD9	636	Q8NDG6
FDLSRYGFGLMQPEH	PTGIS	476	Q16647
MAFGDPHYRTFDGRL	KCP	1216	Q6ZWJ8
QTPMYFFLGHLSFVD	OR5M1	56	Q8NGP8
MFEVFHRGFSFPVNY	ENTPD4	496	Q9Y227
LPYMITLGDAVHNFA	SLC39A4	496	Q6P5W5
GTVQFLMDFVSPQHY	SIMC1	486	Q8NDZ2
RKSLDRFYEMFGHPQ	SHLD1	96	Q8IYI0
GFHAMPSEIFNFLHL	ST8SIA5	346	O15466
NRPGFIKDIHYMYVA	SLC5A3	501	P53794
IMSFPHFYQADERFV	SCARB2	336	Q14108
MYAARNGHPEIVQFL	NUDT12	51	Q9BQG2
MGAYHTIELEPNRQF	PELO	96	Q9BRX2
LGAPRYQHIGLVAMF	ITGAM	421	P11215
AHRNDMETIYPFLFL	PTGES	71	O14684
FMEPYIFGSRLDHDI	MRPS2	101	Q9Y399
ERLTYHMYADPNFVR	SOS1	611	Q07889
DKRLQSPMYFFLGHL	OR9A4	51	Q8NGU2
HQQIYGEHVPRFFVM	SPAG17	1631	Q6Q759
SMADIRAVFNGPYAH	SEMA3D	361	O95025
RYPGSTFMDHVLRYQ	ACLY	691	P53396
DRGPFHRAQEYADFM	BRINP2	61	Q9C0B6
PFNMREFYDRAGHDI	ASIC1	151	P78348
RALVMQLFQDHGFFP	CIC	1471	Q96RK0
AFLVSFMPYHIQRTI	CYSLTR1	241	Q9Y271
NPEHLSYFHFVGRIM	SMURF2	476	Q9HAU4
LGVEHFLREMGQFYE	URGCP	611	Q8TCY9
NQPIAMLYKGLTFFH	TTC13	281	Q8NBP0
FLNHQRFEPMELYGE	ZNF865	36	P0CJ78
LTGMNPFYFHAVNII	TMTC1	106	Q8IUR5
FFAVNQHAGPYVTMI	TRPM6	956	Q9BX84
FAVRYLTSEMHGARP	VWF	1776	P04275
QQAAHYMFFPSVVLS	REV3L	791	O60673
QYLAFMQPHLLGNEF	PPM1H	316	Q9ULR3
FVFILNASLPYHMLA	TMEM131	1091	Q92545
MVPEGQFDHFLVQYR	TNXB	3081	P22105
PMQVLFSGEATHRKY	SMOX	511	Q9NWM0
PSRYVLGMQELFRGH	THOC3	31	Q96J01
TGHPLAMEVRDLYVF	USP49	61	Q70CQ1
RFVSKMFHPNVYADG	UBE2A	71	P49459
RFFYQRLVEFMASGP	NME6	66	O75414
YPLFQDVHVMIFVGF	RHAG	51	Q02094
RTVQMDHTFFPGYRK	XDH	381	P47989
FSVLFTPYHVMRNVR	SUCNR1	241	Q9BXA5
NPVFYFLLGDHFRDM	SUCNR1	291	Q9BXA5
DVPNTMLDLFFHYVF	PPP6R1	381	Q9UPN7
AFQFRLHFGHPAIMN	LGALS14	51	Q8TCE9
LPEHNYVVLRYLMGF	ARHGAP8	341	P85298
DMFRALVPALGHYSQ	UEVLD	271	Q8IX04
FSFGYHLTLPQANMV	TOMM40L	246	Q969M1
FARHPTNGFELYSMV	PPIP5K2	1111	O43314
LFKQYRNHSPLMSFG	TTC39C	51	Q8N584
RLHQPYEAARMFFEG	TRANK1	61	O15050
MSPFFLRQYVKGHAA	UBR4	3136	Q5T4S7
FLAHYFENMGLRSPV	TPGS1	66	Q6ZTW0
AKRARGNVFMYHAPE	TG	2601	P01266
ALRHGAVMYQFFCPA	ZP2	126	Q05996
YVSPADSPFRHIFMG	TFR2	721	Q9UP52
RFLSKMFHPNVYADG	UBE2B	71	P63146
LEGVSREQFMQHLYP	TYW5	11	A2RUC4
LYAHGVFLIMTRPSA	TMEM145	391	Q8NBT3
IYAFPAGHASRAAMV	PLPP7	186	Q8NBV4
FMTHYLREGEPYLNT	TM6SF1	91	Q9BZW5
TNRIGYHIPMFAGFV	SLC18A1	161	P54219
VAKRLQDYGFHAPTM	GLDC	881	P23378
LDSPRAIVLYHEMGF	LRP4	1166	O75096
MRNPGERSFHIFYQL	MYO1E	201	Q12965
ELFKVINMSYHPRGN	ART4	251	Q93070